Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-06 Purchase |
2024-02-06 1:10 pm |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
2,500 | $0.782 | $1,955 | 8,918 (Direct) |
View |
2022-06-06 Purchase |
2023-02-07 4:54 pm |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
5,000 | $1.411 | $7,055 | 6,418 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-07-23 Option Award |
2024-07-24 5:26 pm |
N/A 2034-07-22 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Operating Officer |
155,000 | $0 | 155,000 (Direct) |
View |
2024-03-04 Option Award |
2024-03-06 1:29 pm |
N/A 2034-03-03 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
235,000 | $0 | 235,000 (Direct) |
View |
2023-02-27 Option Award |
2023-02-28 4:31 pm |
N/A 2033-02-26 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
228,000 | $0 | 228,000 (Direct) |
View |
2022-02-18 Option Award |
2022-02-23 9:22 pm |
N/A 2032-02-17 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
190,000 | $0 | 190,000 (Direct) |
View |
2021-02-04 Option Award |
2021-02-08 5:09 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2021-02-04 5:49 pm |
N/A 2027-01-17 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
0 | $0 | 262,724 (Direct) |
View |